Craig Adeyanju

InvestorPlace Contributor

Craig Adeyanju enjoys to unearth awesome growth and value stocks and educate investors about the companies behind them. He believes that the best companies to invest in are those that genuinely solve a problem.

His work has appeared on sites like TheStreet, The Motley Fool, Benzinga among others.

Recent Articles

ZOM Stock: Pros and Cons of Buying Zomedica Ahead of Key Product Launch

By Craig Adeyanju, InvestorPlace Contributor

ZOM Stock has risen by more than 1,000% in the last three months as the launch of Truforma looms. However, Zomedica investors may in for a shocker.

Is Palantir Stock a Buy Despite Uncertainties?

By Craig Adeyanju, InvestorPlace Contributor

PLTR stock has been an investor darling since debuting on the NYSE, but you know consider its growth prospect before buying.

Why Tesla Stock Could Continue to Soar

By Craig Adeyanju, InvestorPlace Contributor

Historical performance has shows that innovative companies significantly outperform the market. Tesla stock leads the industry in that area.

Why Sundial Is a Buy Despite the Artificial Rally

By Craig Adeyanju, InvestorPlace Contributor

While the recent rally of SNDL stock has coincided with r/WallStreetBet's actions against hedge funds, Sundial remains an attractive growth play.

Zcash Looks Cheaper Than Bitcoin, But It’s Not a Safe Buy

By Craig Adeyanju, InvestorPlace Contributor

Regulatory uncertainties makes Zcash and other privacy coins a tough buy. A sustained regualtory crackdown could send prices crashing.

Load More